Patent US4965253A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4965253A Expired / Lapsed US ⏱️ 0.0 years remaining

Viscoelastic material for ophthalmic surgery

Assignee: University of Florida Research Foundation Inc
•
Filing: 1987-10-14
•
Granted: 1990-10-23
•
Expires: 2007-10-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An ophthalmic surgical procedure wherein the anterior or posterior chamber of the eye is filled with viscoelastic space-filling and ocular tissue protective surgical material, the improvement comprising the utilization therein of a composition particularly adapted for use as an ophthalmic viscoelastic surgical material in the anterior or posterior chamber of the eye consisting of an aqueous solution containing from about 1.5% to about 25%, by weight, of a physiologically acceptable, water-soluble polyvinylpyrrolidone polymer or polyvinylpyrrolidone copolymer, having a molecular weight greater than 500,000, said aqueous solution having a viscosity greater than about 5,000 centipoises, measured at 25 DEG C. using a Brookfield viscometer.

Inventors

  • 👤 Eugene P. Goldberg
  • 👤 Moshe Yalon

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 18:34
CPC Classifications
A; A61; A61L; A61L31/00; A61L31/14; A61L31/145; A61K; A61K31/00; A61K31/74; A61K31/785; A61K31/787; A61K31/79; A61K9/00; A61K9/0012; A61K9/0048; A61L31/04; A61L31/041; A61L31/048; A61L2430/00; A61L2430/16

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 72 words
A composition particularly adapted for use as an ophthalmic viscoelastic surgical material in the anterior or posterior chamber of the eye consisting of an aqueous solution containing at least about 1.5% to about 25%, by weight, of a physiologically acceptable, water-soluble polyvinylpyrrolidone polymer or polyvinylpyrrolidone copolymer, having a molecular weight greater than 500,000, said aqueous solution having a viscosity greater than about 5,000 centipoises, measured at 25° C. using a Brookfield viscometer.
Claim 2
Dependent Claim 72 words
A composition particularly adapted for use as an ophthalmic viscoelastic surgical material in the anterior or posterior chamber of the eye consisting of an aqueous solution containing at least about 1.5% to about 25%, by weight, of a physiologically acceptable, water-soluble polyvinylpyrrolidone polymer or polyvinylpyrrolidone copolymer, having a molecular weight greater than 500,000, said aqueous solution having a viscosity greater than about 5,000 centipoises, measured at 25° C. using a Brookfield viscometer.
Claim 3
Dependent Claim 17 words
The composition of claim 1 wherein said aqueous solution comprises a physiological saline solution of said polyvinylpyrrolidone.
Claim 4
Dependent Claim 18 words
The composition of claim 1 wherein said aqueous solution comprises a buffered physiological saline solution of said polyvinylpyrrolidone.
Claim 5
Dependent Claim 21 words
The composition of claim 1 wherein said copolymer comprises at least about 50 mol. % N-Vinylpyrrolidone and the comonomer is hydrophilic.
Claim 6
Dependent Claim 19 words
The composition of claim 1 wherein said copolymer comprises a copolymer of N-Vinylpyrrolidone and an anionic or cationic comonomer.
Claim 7
Dependent Claim 24 words
The composition of claim 1 wherein said solution of polyvinylpyrrolidone has a viscosity in the range of from about 5,000 to about 500,000 cps.
Claim 8
Dependent Claim 18 words
The composition of claim 1 additionally containing one or more different viscoelastic material miscible with said polyvinylpyrrolidone solution.
Claim 9
Dependent Claim 23 words
The composition of claim 7 wherein said different viscoelastic material is selected from the group consisting of hyaluronic acid, chondroitin sulfate and carboxymethylcellulose.
Claim 10
Dependent Claim 29 words
The composition of claim 1 or 7 wherein said compositions are useful as a vitreous replacement or injectable into the vitreous of the eye in an ophthalmic surgical procedure.
Claim 11
Dependent Claim 25 words
A composition according to claim 1 wherein said polyvinylpyrrolidone or polyvinylpyrrolidone copolymer is prepared by gamma-irradiation induced polymerization of N-vinylpyrrolidone in a substantially aqueous solution.
Claim 12
Dependent Claim 42 words
In an ophthalmic surgical procedure wherein the anterior or posterior chamber of the eye is filled with a viscoelastic space-filling and ocular tissue protective surgical material, the improvement comprising the utilization therein of the composition of claim 1 as said surgical material.
Claim 13
Dependent Claim 15 words
An ophthalmic surgical procedure according to claim 11 wherein said surgery comprises intraocular lens implantation.
Claim 14
Dependent Claim 14 words
An ophthalmic surgical procedure according to claim 11 wherein said surgery comprises cataract surgery.
Claim 15
Dependent Claim 15 words
An ophthalmic surgical procedure according to claim 11 wherein said surgery comprises a corneal transplant.
Claim 16
Dependent Claim 14 words
An ophthalmic surgical procedure according to claim 11 wherein said surgery comprises glaucoma surgery.
Claim 17
Dependent Claim 14 words
An ophthalmic surgical procedure according to claim 11 wherein said surgery comprises retinal surgery.
Claim 18
Dependent Claim 14 words
An ophthalmic surgical procedure according to claim 11 wherein said surgery comprises vitreous replacement.
Claim 19
Dependent Claim 26 words
An ophthalmic surgical procedure according to claim 11 wherein said ophthalmic surgical material additionally contains one or more different viscoelastic material miscible with said polyvinylpyrrolidone solution.
Claim 20
Dependent Claim 26 words
An ophthalmic surgical procedure according to claim 18 wherein said different viscoelastic material is selected from the group consisting of hyaluronic acid, chondroitin sulfate and carboxymethylcellulose.

References Cited (Backward Citations)

US4003991A Cited
US4141973A Cited
US4141973B1 Cited
US4136173A Cited
US4328803A Cited
US4328803B1 Cited
US4486416A Cited
WO1986000079A1 Cited
US4604217A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-10-22 1994-04-23 1994-10-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-10-22 1998-04-23 1998-10-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-10-22 2002-04-23 2002-10-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag